Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460354 · ClinicalTrials.gov registry record · Phase 1
Metformin and Congenital Nephrogenic Diabetes Insipidus
A Phase 1 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT02460354 is a Phase 1 study that was terminated before completion, run by Emory University. The registered enrollment target is 2 participants.
The verdict
NCT02460354, a Phase 1 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether metformin can increase urine concentration (osmolality) and decrease the amount of urine in patients with congenital nephrogenic diabetes insipidus (NDI).
Interventions
- DRUG Metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460354
The ClinicalTrials.gov registry entry for NCT02460354 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin is the first listed.
NCT02460354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02460354 about?
NCT02460354 is a clinical study titled "Metformin and Congenital Nephrogenic Diabetes Insipidus". The purpose of this study is to determine whether metformin can increase urine concentration (osmolality) and decrease the amount of urine in patients with congenital nephrogenic diabetes insipidus (NDI).
What is the current status of trial NCT02460354?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2015-09. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02460354?
The interventions under investigation include: Metformin (DRUG).
Who is sponsoring clinical trial NCT02460354?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.